Glioblastoma is characterized by rapid growth, invasive behavior, and poor prognosis [1]. Despite advancements in therapeutic approaches, including surgery and chemoradiotherapy, the median survival is dismally low [2,3]. Effective monitoring of glioblastoma is critical for optimizing treatment strategies and improving patient outcomes.